There is a trial of strength at the cellular level. Cells are in constant competition with each other and so eliminate ...

Adia Labs introduced AdiaVita, a high-potency stem cell product containing 100 million cells and 3 trillion exosomes per dose, designed for clinical research and therapeutic use. A future product ...

The previous 12 months have seen considerable progress in cell and gene therapies, with the first solid tumor products receiving regulatory approval and applicants for treating diabetes and heart ...

Rexlemestrocel-L for Chronic Low Back Pain associated with Degenerative Disc Disease - Phase 3 Program The confirmatory Phase 3 trial of Mesoblast's second generation allogeneic, STRO3-immunoselected, ...

Imaging the molecules in the spindle of a dividing cell – a longstanding challenge at MBL and elsewhere -- is another example. "With traditional microscopy, including polarized light ...

Like other biological drugs, CAR-T cell products can trigger unwanted immune responses in patients receiving the treatment. This might lead to treatment failure or life-threatening consequences. This ...

Participants in the study, which enrolled from 2004 to 2009, were infused with two immune effector cell products -- activated T cells expanded with OKT3 antibody and Epstein-Barr virus (EBV ...